Mumbai (Maharashtra) [India], October 29: Fischer Medical Ventures Limited(FISCHER | 524743 | INE771F01041), one of the leading companies engaged in the business of developing innovative, cost-effective medical imaging, advanced diagnostics and point-of-care diagnostic solutions, has announced its unaudited financial results for Q2 & H1 FY26.
Key Consolidated Financial Highlights
Q2 FY26 Key Financial Highlights
• Total Income of ₹ 88.79 Cr, YoY growth of 122.64%
• EBITDA…








